64353-88-4

Usage

Uses

Used in Pharmaceutical Industry:
N-(5-amino-2-methoxyphenyl)acetamide(SALTDATA: 1HCl 1H2O) is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure, which includes an amino group and a methoxy group attached to a phenyl ring, makes it a versatile building block for the development of new drugs.
Used in Medical Research:
N-(5-amino-2-methoxyphenyl)acetamide(SALTDATA: 1HCl 1H2O) is used as a research tool in the study of various biological processes and disease mechanisms. Its potential applications in drug development make it a valuable compound for investigating the effects of different chemical modifications on biological activity.
Used in Drug Development:
N-(5-amino-2-methoxyphenyl)acetamide(SALTDATA: 1HCl 1H2O) is used as a potential treatment for certain medical conditions. Its unique structure and properties may offer therapeutic benefits in the treatment of various diseases, and ongoing research is focused on identifying its specific applications and optimizing its use in medicine.

InChI:InChI=1/C9H12N2O2/c1-6(12)11-8-5-7(10)3-4-9(8)13-2/h3-5H,10H2,1-2H3,(H,11,12)

Upstream product

• 33721-54-9 N-(2-methoxy-5-nitrophenyl)acetamide 
• 116496-77-6 acetic acid-(2-ethoxy-5-nitro-anilide) 
• 7439-89-6 iron 

Downstream Products

• 188630-75-3 N-(5-methanesulfonamido-2-methoxy)phenylacetamide 
• 953391-96-3 N-[5-{[(4-bromo-3-fluorophenyl)sulfonyl]amino}-2-(methyloxy)phenyl]acetamide 
• 500758-42-9 N-(3-dimethylamino-6-methoxyphenyl)acetamide 
• 953392-39-7 N₁-[5-({[3-fluoro-4-(5-methyl-2-furanyl)phenyl]sulfonyl}amino)-2-(methyloxy)phenyl]-2-methylalaninamide hydrochloride 
• 953391-99-6 1,1-dimethylethyl (2-{[5-({[3-fluoro-4-(5-methyl-2-furanyl)phenyl]sulfonyl}amino)-2-(methyloxy)phenyl]amino}-1,1-dimethyl-2-oxoethyl)carbamate 
• 953391-97-4 N-[5-({[3-fluoro-4-(5-methyl-2-furanyl)phenyl]sulfonyl}amino)-2-(methyloxy)phenyl]acetamide 
• 953391-98-5 N-[3-amino-4-(methyloxy)phenyl]-3-fluoro-4-(5-methyl-2-furanyl)benzenesulfonamide 
• 1403886-33-8 N-[2-methoxy-5-(8-methoxy-2H-pyrazolo[3,4-c]quinolin-4-ylamino)-phenyl]-acetamide 
• 503812-11-1 ethyl (E)-3-[3-(acetylamino)-4-methoxyanilino]-2-cyano-2-propenoate 

Relevant academic research and scientific papers

ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS

The present invention therefore provides compounds of formula (I) or pharmaceutically acceptable salts thereof: (I) processes for their preparation, pharmaceutical compositions containing the same and to their use in the treatment of gastrointestinal and other disorders.

TRICYCLIC PROTEIN KINASE INHIBITORS

This invention provides compounds of Formula (I), where A'', Z, X and n are defined herein, or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of polycystic kidney disease.

Tricyclic protein kinase inhibitors

This invention provides compounds of Formula (I), where A″, Z, X and n are defined herein, or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of polycystic kidney disease.

3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors

This invention provides compounds of Formula (I), having the structure where T, Z, X, A, R1, R2a, R2b, R2c, R3, R4, and n are defined herein, or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of osteoporosis and polycystic kidney disease.

Synthesis and antitumor activity of fused quinoline derivatives. IV. Novel 11-aminoindolo[3,2-b]quinolines

Indolo[3,2-b]quinoline derivatives (1) having various amine moieties were prepared and their antitumor activities against P388 leukemia in mice were evaluated, for the purpose of gaining an insight into the role of the amine moiety in the antitumor activity and searching for an effective amine moiety. Introduction of a methylene group between the phenyl group and amino or methanesulfonamido group resulted in decrease or loss of activity.

Substituted 2H-pyran-2, 6(3H)-dione derivatives

Substituted 2H-pyran-2,6(3H)-dione derivatives useful in the treatment of allergic conditions are prepared by reaction of 3,5-diacetyl-4,6-dihydroxy-2H-pyran-2-one with an appropriate aniline.